Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
4
Papers
38
Citations
2
h-index
1
i10-index
C. Ceballos is an academic researcher from University of California, Los Angeles. The author has contributed to research in topics: Pancreatic function and diabetes & Diabetes and associated disorders & Mesenchymal stem cell research. The author has an h-index of 2, co-authored 4 publications.
https://doi.org/10.1016/s0140-6736(19)31149-3
https://doi.org/10.1016/s0140-6736(19)31150-x
Click to start Chat